Multiplex Immunoassay for HbA1c and Hemoglobin Variant Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current HbA1c assays face inaccuracies due to the presence of hemoglobin variants and thalassemias, as existing methods like HPLC struggle to simultaneously detect HbA1c levels and variant/thalassemia status, especially in individuals with prevalent variants such as HbS, HbC, HbE, and HbD, leading to compromised glycemic control in diabetes management.
Innovation Solution
A multiplex immunoassay using specific monoclonal antibodies that selectively bind to HbA1c and common hemoglobin variants, allowing for simultaneous detection and measurement of HbA1c levels relative to total hemoglobin, while correcting for variant presence, enabling accurate glycated hemoglobin determination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If HPLC is used to detect HbA1c levels, then HbA1c measurement is obtained, but the ability to simultaneously detect hemoglobin variants and thalassemias is compromised
Solution Approach 1:
The assay is segmented into multiple independent detection channels, each targeting a specific hemoglobin species (HbA1c, HbS, HbC, HbE, HbD, etc.) using specific antibodies. This allows parallel measurement of HbA1c and various hemoglobin variants without interference, resolving the contradiction between HbA1c measurement precision and simultaneous variant detection capability
Solution Approach 2:
The immunoassay system is designed with multi-functionality to perform both HbA1c quantification and hemoglobin variant identification in a single test. By incorporating multiple analyte-specific antibodies and detection reagents, the system simultaneously achieves accurate glycated hemoglobin measurement and comprehensive variant screening, eliminating the need for separate HPLC methods
2Measurement precision
If separate assays are used for HbA1c and hemoglobin variants, then each measurement can be optimized, but the overall testing time and complexity increase
Solution Approach 1:
Multiple separate assays for HbA1c and hemoglobin variants are merged into a single multiplexed immunoassay. Different antibody-coated beads or detection reagents are combined in one reaction mixture, allowing simultaneous measurement of all targets in a single incubation and detection step. This maintains the precision of individual optimized assays while reducing total testing time and operational complexity
3Ease of operation
If HbA1c assay is performed without correcting for hemoglobin variants, then the assay procedure is simpler, but the glycemic control determination becomes inaccurate
Solution Approach 1:
The system introduces variant detection as an intermediary step that enables accurate HbA1c interpretation. By first identifying and quantifying hemoglobin variants using specific antibodies, the system can then apply appropriate correction factors or selective counting methods to determine accurate glycated hemoglobin levels. This intermediary variant detection step maintains procedural simplicity while ensuring accurate glycemic control determination in patients with hemoglobinopathies
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides accurate and simultaneous detection of HbA1c and hemoglobin variants, improving glycemic control by correcting for variant impacts, thus enhancing the reliability of diabetes management.
Implementation Method 1
A multiplex immunoassay using specific monoclonal antibodies that selectively bind to HbA1c and common hemoglobin variants
Data Source
AI summary
Hemoglobin, its variants, and glycated forms of each are determined individually in a multiplex assay that permits correction of the measured level of HbA1c to account for glycated variants and other factors related to the inclusion of the variants in the sample. New antibodies that are particularly well adapted to the multiplex assay are also provided.